AptarGroup has inaugurated a new pharmaceutical manufacturing facility in Taloja, near Mumbai. The facility will support the production of devices such as pressurized metered dose inhaler (pMDI) valves, breath-actuated devices, and single-dose nasal sprays.
Spanning an additional 4,400 square meters, the Taloja plant is located adjacent to the company’s existing facility, which became operational in 2023. The new facility aims to enhance local manufacturing capacity and cater to increasing regional demand for drug delivery systems.
According to the company, the plant will also enable Indian pharmaceutical firms to expand the availability of inhalers and nasal sprays in domestic and international markets.